RNXT

RenovoRx, Inc. Common Stock

1.12

USD

RNXT Earnings Reports

Positive Surprise Ratio

RNXT beat 11 of 17 last estimates.

65%

Next Report

Date of Next Report

Mar 30, 2026

Estimate for Q4 25 (Revenue/ EPS)

$456.28K

-$0.08

Implied change from Q3 25 (Revenue/ EPS)

+71.53%

Implied change from Q4 24 (Revenue/ EPS)

+961.11%

-38.46%

RenovoRx, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, RNXT reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.08 USD, resulting in a 1.96% surprise. Revenue reached 266.00 thousand, compared to an expected 413.44 thousand, with a -35.66% difference. The market reacted with a -23.03% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.08 USD, with revenue projected to reach 456.28 thousand USD, implying an increase of 0.00% EPS, and increase of 71.53% in Revenue from the last quarter.

FAQ

What were RenovoRx, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, RenovoRx, Inc. Common Stock reported EPS of -$0.08, beating estimates by 1.96%, and revenue of $266.00K, -35.66% below expectations.

How did the market react to RenovoRx, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -23.03%, changed from $0.97 before the earnings release to $0.75 the day after.

When is RenovoRx, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 30, 2026.

What are the forecasts for RenovoRx, Inc. Common Stock's next earnings report?

Based on 6 analysts, RenovoRx, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $456.28K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.